Benzodiazepine Use and Misuse Among Patients in a Methadone Program-Reference-Cited by-同舟云学术

Benzodiazepine Use and Misuse Among Patients in a Methadone Program

Published:2011-05-19 Issue:1 Volume:11 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

Chen Kevin W,Berger Christine C,Forde Darlene P,D'Adamo Christopher,Weintraub Eric,Gandhi Devang

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/1471-244X-11-90.pdf

Reference27 articles.

1. Ashton H: The diagnosis and management of benzodiazepine dependence. Current opinion in Psychiatry. 2005, 18 (3): 249-10.1097/01.yco.0000165594.60434.84.

2. Posternak MA, Mueller TI: Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. The American Journal on Addictions. 2001, 10 (1): 48-68. 10.1080/105504901750160484.

3. Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R: Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Ir Med J. 2007, 100 (3): 393-

4. Meiler A, Mino A, Chatton A, Broers B: Benzodiazepine use in a methadone maintenance programme: patient characteristics and the physician's dilemma. Schweizer Archiv für Neurologie und Psychiatrie. 2005, 156 (6): 310-317.

5. Peles E, Schreiber S, Adelson M: 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend. 2010, 107 (2-3): 141-148. 10.1016/j.drugalcdep.2009.09.013.

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “I Can Combine Those Things to be a Superhero” a Qualitative Study of the Motivations for High-Risk Polysubstance Use;Journal of Drug Issues;2024-08-23

2. Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study;BMJ Open;2024-03

3. Is the SCL90-based five-dimensional structure able to differentiate heroin use disorder patients with low and high benzodiazepine dependence symptomatology?;Heroin Addiction and Related Clinical Problems;2024-03

4. Longitudinal associations between anxiety sensitivity and substance use in adolescents: Mediation by depressive affect.;Experimental and Clinical Psychopharmacology;2024-02

5. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022;International Journal of Drug Policy;2023-12